Back to Home
JNC news
JNC appears in 1 story we have published in October 2026, mostly in our Funding coverage. It is most often reported alongside SEGNOS.
Latest development
SEGNOS raises pre-Series A for nanotech blood testing platform Therma-Max
Japanese biotechnology startup SEGNOS has closed a pre-Series A funding round led by BP Capital to accelerate the development of its temperature-responsive magnetic nanoparticle technology, Therma-Max. The funds will support research into healthcare testing and in vitro diagnostic drugs, aiming to improve sensitivity and reduce costs compared to conventional methods.
23 October 2026
